Effect on Beta Cell Function and Glycaemic Control After Insulin and Exenatide Sequential Therapy

Clinical trial NCT02129985 · UNKNOWN

Trial details

NCT number: NCT02129985
Sponsor: xiaolong zhao
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2014-02-01
Primary completion: 2015-06-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.